Mutz Christopher sold ANIP
February 20, 2026 · Form 4 insider transaction
Mutz Christopher sold 5,323 shares of ANI Pharmaceuticals, Inc. at $78.02 per share, a transaction worth $415.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,323
Price
$78.02
Total value
$415.3K
InsiderMutz Christopher
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 20, 2026
Filing dateFebruary 23, 2026
Shares owned after84,840
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.; The shares were sold in multiple trades at prices ranging from $77.20 to $78.58. The price reported above reflects the weighted average sales price.